platinum has been researched along with Genetic Predisposition in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 16 (76.19) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, S; Singh, N; Walia, HK | 1 |
| Arakawa, Y; Hasegawa, D; Hata, K; Imamura, T; Inoue, A; Ishimaru, S; Ishiwata, K; Ito, S; Kato, M; Kawai, T; Kiyokawa, N; Kiyotani, C; Koh, K; Manabe, A; Matsumoto, K; Nakabayashi, K; Niwa, A; Ogata-Kawata, H; Ogawa, S; Okamura, K; Osumi, T; Sakamoto, M; Sato-Otsubo, A; Shioda, Y; Shirai, R; Takagi, M; Terashima, K; Tomizawa, D; Tsujimoto, SI; Yang, JJ; Yang, W; Yoshida, K; Yoshida, M; Yoshioka, T; Yuza, Y | 1 |
| Kanai, M; Kondo, T; Matsumori, T; Murakami, H; Muto, M; Nagai, K; Sunami, T; Uchida, Y; Uza, N; Yamada, A; Yamada, T; Yokode, M | 1 |
| Bakir, MA; Benton, B; Brenton, JD; Broderick, P; Chowdhury, S; Cornish, AJ; de Castro, DG; Dudakia, D; Grist, E; Hiley, C; Holryod, A; Houlston, RS; Huddart, R; Levy, M; Litchfield, K; Loveday, C; Macintyre, G; O'Connor, S; Powles, T; Proszek, PZ; Reid, A; Santo, F; Shipley, J; Swanton, C; Turnbull, C | 1 |
| Behera, D; Lawania, S; Sharma, S; Singh, N | 1 |
| Gong, WJ; Han, Y; Hu, L; Huang, DD; Huang, H; Liu, RJ; Lv, YN; Ma, LY; Shi, SJ; Wu, SL; Xu, JQ; Zhang, Y | 1 |
| Alewine, C; Calzone, K; Churpek, JE; Desai, A; Gadiraju, M; Gao, S; Gulsuner, S; Hassan, R; Hesdorffer, M; Khan, J; Kindler, HL; King, MC; Lee, MK; Mian, I; Morrow, B; Padiernos, E; Panou, V; Patel, S; Raffeld, M; Schrump, DS; Steinberg, SM; Thomas, A; Walsh, T; Wei, JS; Xi, L; Zhang, J | 1 |
| Jiang, L; Yan, B; Zhang, W | 1 |
| Chen, X; Gong, Y; He, J; Xia, J; Zhu, N | 1 |
| Xian, L; Yang, Y | 1 |
| Li, L; Wan, C; Wen, FQ | 1 |
| Cao, S; Dai, J; Hu, Z; Ma, H; Shen, H; Shen, W; Shu, Y; Wang, C; Xu, L; Yin, R; Zhu, M | 1 |
| Han, Y; Hu, R; Jiao, Y; Li, J; Weng, Q; Yuan, Z | 1 |
| Bonomi, L; Caiola, E; Ganzinelli, M; Marabese, M; Piva, S; Rulli, E | 1 |
| Fallowfield, L; Howitt, BE; Karlan, BY; Matulonis, UA; Sehouli, J; Sood, AK | 1 |
| Eileen Dolan, M; Gamazon, E; Kistner-Griffin, EO; O'Donnell, PH; Stark, AL; Stephanie Huang, R; Zhang, W | 1 |
| Cao, Y; Chen, B; Cheng, H; Cheng, L; Feng, J; Li, F; Sun, N; Sun, X | 1 |
| Liu, GY; Zhang, W | 1 |
| Bian, B; Hu, N; Li, Y; Wu, F; Xu, G; Zheng, Y | 1 |
| Guo, S; Hu, J; Jin, L; Li, Q; Liu, J; Lu, D; Wang, JC; Wang, L; Wu, J; Ying, J; Zhao, N; Zhou, Y; Zou, H | 1 |
| Couzin, J | 1 |
8 review(s) available for platinum and Genetic Predisposition
| Article | Year |
|---|---|
STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Case-Control Studies; Female; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Polymorphism, Single Nucleotide; Prognosis; STAT3 Transcription Factor; Treatment Outcome | 2019 |
Predictive effect of XRCC3 Thr241Met polymorphism on platinum-based chemotherapy in lung cancer patients: meta-analysis.
Topics: Amino Acid Substitution; DNA-Binding Proteins; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Lung Neoplasms; Platinum; Polymorphism, Genetic; Prognosis; Survival Analysis; Treatment Outcome | 2013 |
Influence of methylenetetrahydrofolate reductase C677T polymorphism on the risk of lung cancer and the clinical response to platinum-based chemotherapy for advanced non-small cell lung cancer: an updated meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Methylenetetrahydrofolate Reductase (NADPH2); Platinum; Polymorphism, Genetic | 2013 |
The association between the GSTP1 A313G and GSTM1 null/present polymorphisms and the treatment response of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients: a meta-analysis.
Topics: Asian People; Biomarkers, Pharmacological; Carcinoma, Non-Small-Cell Lung; Genetic Predisposition to Disease; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Platinum; Polymorphism, Single Nucleotide | 2014 |
Polymorphisms in the XRCC1 gene are associated with treatment response to platinum chemotherapy in advanced non-small cell lung cancer patients based on meta-analysis.
Topics: Alleles; Carcinoma, Non-Small-Cell Lung; China; DNA-Binding Proteins; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Treatment Outcome; X-ray Repair Cross Complementing Protein 1 | 2014 |
Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; DNA-Binding Proteins; Genetic Predisposition to Disease; Genotype; Humans; Lung Neoplasms; Odds Ratio; Pharmacogenetics; Platinum; Polymorphism, Single Nucleotide; Prognosis; Treatment Outcome; X-ray Repair Cross Complementing Protein 1 | 2015 |
Ovarian cancer.
Topics: Antineoplastic Agents; BRCA2 Protein; CA-125 Antigen; Contraceptives, Oral, Hormonal; Early Detection of Cancer; Female; Genetic Predisposition to Disease; Gynecologic Surgical Procedures; Humans; Mass Screening; Membrane Proteins; Ovarian Neoplasms; Ovariectomy; Parity; Platinum; Risk Factors; Sterilization, Tubal; Ubiquitin-Protein Ligases | 2016 |
Predictive value of XRCC1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: a systematic review and meta-analysis.
Topics: Alleles; Carcinoma, Non-Small-Cell Lung; DNA-Binding Proteins; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Neoplasm Staging; Platinum; Polymorphism, Genetic; Prognosis; Treatment Outcome; X-ray Repair Cross Complementing Protein 1 | 2012 |
2 trial(s) available for platinum and Genetic Predisposition
| Article | Year |
|---|---|
DNA repair gene polymorphisms in non-small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; DNA Repair; Female; Gene Frequency; Genes, erbB-1; Genes, ras; Genetic Predisposition to Disease; Genotype; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis; Risk Factors | 2016 |
Polymorphisms in hMSH2 and hMLH1 and response to platinum-based chemotherapy in advanced non-small-cell lung cancer patients.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Antineoplastic Agents; Asian People; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Resistance, Neoplasm; Female; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Male; Middle Aged; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Staging; Nuclear Proteins; Platinum; Polymorphism, Genetic; Polymorphism, Single Nucleotide | 2010 |
11 other study(ies) available for platinum and Genetic Predisposition
| Article | Year |
|---|---|
Association of
Topics: Antineoplastic Agents; Arylamine N-Acetyltransferase; Female; Genetic Predisposition to Disease; Humans; India; Lung Neoplasms; Male; Middle Aged; Platinum; Polymorphism, Single Nucleotide; Prognosis; Smoking; Survival Analysis | 2022 |
Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers.
Topics: Brain Neoplasms; Child; DEAD-box RNA Helicases; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Leukemia; Neoplasms, Second Primary; Platinum; Prevalence; Ribonuclease III | 2023 |
Exceptional Response of Pancreatic Acinar Cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a Germline BRCA2 Variant.
Topics: Adult; Bile Duct Neoplasms; BRCA1 Protein; BRCA2 Protein; Carcinoma, Acinar Cell; Genetic Predisposition to Disease; Germ Cells; Germ-Line Mutation; Humans; Male; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Platinum | 2022 |
Genomic landscape of platinum resistant and sensitive testicular cancers.
Topics: DNA Copy Number Variations; Drug Resistance, Neoplasm; Exome Sequencing; Genetic Predisposition to Disease; Genomics; Humans; Male; Mutation; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Platinum; Proto-Oncogene Proteins c-kit; ras Proteins; Signal Transduction; Testicular Neoplasms | 2020 |
Xeroderma pigmentosum complementation group D polymorphism toward lung cancer susceptibility survival and response in patients treated with platinum chemotherapy.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Female; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis; Treatment Outcome; Xeroderma Pigmentosum | 2017 |
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; DNA Repair; Female; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Platinum; Pleural Neoplasms; Survival Analysis; Tumor Suppressor Proteins; Ubiquitin Thiolesterase; Young Adult | 2019 |
Genome-wide Association Study on Platinum-induced Hepatotoxicity in Non-Small Cell Lung Cancer Patients.
Topics: Asian People; Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Demography; Ethnicity; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Polymorphism, Single Nucleotide; Risk Factors | 2015 |
Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants.
Topics: Asian People; Black People; Carboplatin; Cell Line, Transformed; Cisplatin; Genetic Predisposition to Disease; Genetic Variation; Genetics, Population; Genome-Wide Association Study; Humans; Inhibitory Concentration 50; Lymphocytes; Pharmacogenetics; Phenotype; Platinum; White People | 2010 |
Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?
Topics: Age Factors; Asian People; Disease-Free Survival; Female; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Genetic Testing; Humans; Mutation; Ovarian Neoplasms; Platinum; Remission Induction; Risk; Survival Rate | 2012 |
Galectin-3 genetic variants are associated with platinum-based chemotherapy response and prognosis in patients with NSCLC.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Galectin 3; Genetic Predisposition to Disease; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Polymorphism, Single Nucleotide; Prognosis; Proportional Hazards Models; Survival Analysis | 2012 |
Choices--and uncertainties--for women with BRCA mutations.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Heterozygote; Humans; Mastectomy; Mutation; Ovarian Neoplasms; Ovariectomy; Platinum; Risk Assessment; Tamoxifen | 2003 |